Working… Menu

A Study to Assess the Receptor Occupancy of CD86 and CD80 in Subjects With Rheumatoid Arthritis Initiating Abatacept

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01339481
Recruitment Status : Completed
First Posted : April 20, 2011
Last Update Posted : November 29, 2011
Perseid Therapeutics LLC
Information provided by (Responsible Party):
Astellas Pharma Inc

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 2011
Actual Study Completion Date : October 2011